Medtronic shareholders approve all proposals at 2025 AGM including director elections and bylaw amendments

Medtronic plc

All 12 director nominees elected; Craig Arnold received lowest support at 86.7% of votes cast.
Say-on-pay approved with 93.5% of votes cast in favor; ratification of PwC as auditor passed.
Shareholders approved amendment to Article 177 to capitalize non-distributable reserves and capital reduction to create distributable reserves.
Authority renewed to issue shares, opt out of pre-emption rights, and make overseas share purchases.
Advance notice provisions updated to strengthen shareholder proposal procedural requirements.

item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.